POST COVID MANAGEMENT OF ASTHMA IN CHRONIC ASTHMA PATIENT
RAJAT DASH
GCP, SBP, Odisha, India.
B. RAY *
Post Graduate Department, GCP, SBP, Odisha, India.
S. N. DAS
Post Graduate Department, GCP, SBP, Odisha, India.
SWASTIK KUMAR PUROHIT
GCP, SBP, Odisha, India.
*Author to whom correspondence should be addressed.
Abstract
Asthma is defined as a chronic inflammatory disease of the airways. The chronic inflammation is associated with airway hyper responsiveness (an exaggerated airway narrowing response to triggers, such as allergens and exercise), that leads to recurrent symptoms such as wheezing, dyspnea (shortness of breath), chest tightness and coughing. Asthma is associated with T helper cell type-2 (Th2) immune responses, which are typical of other atopic conditions. Various allergic (e.g., dust mites, cockroach residue, furred animals, moulds, pollens) and non-allergic (e.g., infections, tobacco smoke, cold air, exercise) triggers produce a cascade of immune-mediated events leading to chronic airway inflammation. The Present Review Discuss and Focus about the various Risk factor associated with Covid 19 influenced Asthma Patient with their Possible Management.
Keywords: Asthma, allergy, antigene, antibody, immunnity, cytokines